Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Immuron Submits IND Application To FDA For Travelan

Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA) Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA Clinical Trial to examine a
byBenzinga Newsdesk
December 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA)
  • Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA
  • Clinical Trial to examine a dosing regimen for Travelan more suited for use by the US military
    • Infectious diarrhea is the most common illness reported by travelers
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal

By Jelena Martinovic
January 2, 12:10 PM
Blueberries Medical, a Latin American licensed producer of medicinal cannabis and cannabis-derived products, has announced a non-brokered private placement, to raise approximately CA$1.9m ($1.4m). The company announced the sale of 180,716,00 common shares at CA$0.011 per share. The net proceeds from the sale will be used to repay existing debt and for general corporate and working capital purposes. The offering was led by Terraflos, a Latin American company founded and controlled by Facundo Garreton, who serves as Blueberries' chairman, CEO, and director. Terraflos is exploring opportunities in Argentina, Mexico, and Brazil and plans to expand into those markets in the near future.

ALID